Should You Sell ABVC Biopharma Inc (ABVC) Stock Thursday Morning?

ABVC Biopharma Inc (ABVC) is down Thursday morning, with the stock falling -2.73% in pre-market trading to 1.07. ABVC's short-term technical score of 51 indicates that the stock has traded more bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, ABVC Biopharma Inc ranks higher than 68% of stocks. ABVC Biopharma Inc has risen 19.57% over the past month, closing at $0.90 on October 5. During this period of time, the stock fell as low as $0.81 and as high as $3.35. ABVC has an average analyst recommendation of Sell. The company has an average price target of $20.20.

ABVC has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on ABVC!

See Full ABVC Report

ABVC Biopharma Inc has a Long-Term Technical rank of 78. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 22% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, ABVC ranks better than 129% of stocks.

Important Dates for Investors in ABVC:

-ABVC Biopharma Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-0.98. -We do not have a set dividend date for ABVC Biopharma Inc at this time. Click Here To Get The Full Report on ABVC Biopharma Inc (ABVC)